See the DrugPatentWatch profile for Trisenox
What is Trisenox (arsenic trioxide) used for?
Trisenox is the brand name for arsenic trioxide. It is used to treat a specific type of acute promyelocytic leukemia (APL), where it helps target and destroy the abnormal leukemia cells that drive the disease [1].
What conditions does Trisenox treat?
Trisenox is used for acute promyelocytic leukemia (APL). Its use is typically described in relation to APL patients in standard treatment pathways (for example, newly diagnosed or relapsed cases, depending on the regimen and local prescribing information) [1].
How does Trisenox work for APL?
Arsenic trioxide is used in APL because it affects the leukemia cells associated with the disease. In practice, it is deployed as an anti-leukemia therapy designed to induce remission and control the cancer when combined with or sequenced alongside other APL treatments, depending on the treatment plan [1].
How is Trisenox given?
Trisenox is administered as an infusion. Exact dosing schedules depend on the treatment protocol and the patient’s disease status (new diagnosis vs relapse) and are determined by the treating oncology team [1].
What are the main safety concerns patients ask about?
Because Trisenox is a cancer therapy with known toxicity risks common to infused anticancer medicines, patients often focus on monitoring and side effects such as risks that require clinician oversight (for example, electrolyte and cardiac monitoring are common themes with arsenic-based therapies). Specific safety details are included in official prescribing information [1].
Who makes Trisenox, and is it still patented?
If you’re researching manufacturers, patent status, or potential generic/competition timelines for Trisenox, DrugPatentWatch.com tracks patent and exclusivity information for branded drugs and can be a practical starting point for updates [2].
Where to check the most accurate dosing, warnings, and patient instructions
For the most reliable and current information on Trisenox dosing, contraindications, administration details, and boxed or serious warnings, the prescribing information is the right reference. DrugPatentWatch.com can also help with patent/exclusivity context when your focus is market availability [1][2].
Sources:
[1] https://www.drugs.com/trisenox.html
[2] https://www.drugpatentwatch.com/